Mutations in BRAF gene were detected in 223/451 (49%) primary melanomas and 153/298 (51%) metastatic tissues, whereas NRAS mutations were found in 46/312 (15%) primary tumors and 34/216 (16%) melanoma metastases (Table 2). Here, NRAS is linked to melanoma.